Profile
Scott Youmans is currently the Senior Vice President-Technical Operations at Impel Pharmaceuticals, Inc. Previously, he was the Chief Operating Officer at Atossa Therapeutics, Inc. from 2015 to 2016.
He also held the position of Vice President-Engineering at Pathway Medical Technologies, Inc. Mr. Youmans completed his undergraduate degree at Western Washington University.
Scott Youmans active positions
| Companies | Position | Start |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Chief Tech/Sci/R&D Officer | - |
Former positions of Scott Youmans
| Companies | Position | End |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Chief Operating Officer | 12/02/2016 |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Corporate Officer/Principal | - |
Training of Scott Youmans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Impel Pharmaceuticals, Inc.
Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Health Technology |
Western Washington University
Western Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Scott Youmans
















